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Sacroiliac joint (SIJ)Abstract Background and objective: Sacroiliac joint pain is a common cause for chronic axial low
back pain, with up to 20% prevalence rate. To date, no effective long-term treatment intervention
has been embarked on yet. The aim of our study was to compare steroid block to radiofrequency
ablation for SIJ pain conditions.
Methods: A randomized, blind, study was conducted in 30 patients with sacroiliac joint pain. Fif-
teen patients received radiofrequency denervation of L4–5 primary dorsal rami and S1–3 lateral
sacral branch, and 15 patients received steroid under fluoroscopy. Those in the steroid group
who did not respond to steroid injections were offered to cross over to get radiofrequency ablation.
Results: At 1-, 3- and 6-months post-intervention, 73%, 60% and 53% of patients, respectively,
gained P50% pain relief in the radiofrequency (RF) ablation group. In the steroid group, at one
month postintervention follow-up, only 20% gained P50% pain relief, but failed to show any
improvement at 3 month and 6 month follow-up.
Conclusions: Radiofrequency ablation at L4 and L5 primary dorsal rami and S1–3 lateral sacral
branch may provide effective and longer pain relief compared to the classic intra-articular steroid
injection, in properly selected patients with suspected sacroiliac joint pain. Larger studies are called
for to confirm our results, and lay out the optimal patient selection and treatment parameters for
this poorly comprehended disorder.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Sacroiliac joint pain remains a major challenge for pain clini-
cians and it is accounted for up to 20% of patients with low
back pain [1,2]. In addition to its prevalence, SIJ pain lacks
220 O.H. Salman et al.valid clinical/diagnostic tests and no therapeutic modalities for
long term improvement have been found yet. Whereas some
experts adopt complicated clinical test algorithms as a tool
of SIJ pain diagnosis, others advocate intra articular anesthetic
block as a sole reliable diagnostic test [3–6].
Treatment of SIJ pain is another dilemma and wide range
of therapeutic modalities has been used including pharma-
cotherapy, chiropractic manipulation, SIJ injection (local anes-
thetics; steroid or mixture); and surgical fixation [7–12].
Lateral branch radiofrequency (RF) ablation, has gained
popularity of recent years [13,14]. There have been many stud-
ies, controlled and uncontrolled with promising results [15–17].
However, these studies are distinguished by their wide range of
discrepancies including RF technique, standards definitions,
and more importantly selection criteria.
Selecting the right patient is crucial for any pain manage-
ment intervention [18–20].
Due to its prevalence, diverse pain referral zones, and con-
tention over its innervation, SIJ ablation requires strict patient
selection approach [21,22].
Nevertheless, pain referral pattern from SIJ bears consider-
able variability among patients and in uncontrolled studies
assessing denervation of SIJ, and various researchers have
adopted different radiation maps in the inclusion criteria
[23,24].
As lateral branch ablation does not interfere with the affer-
ent supply from the whole SIJ, different parts of the joint have
various referral zones. Establishing those referral areas suscep-
tible to benefit from RF ablation would save patients from
many unnecessary interventions. Amid this perplexity, we
designed our research to compare radiofrequency ablation to
intra-articular steroid injection for SIJ pain measured by
VAS before and at one, three and six months after
intervention.2. Methodology
This study was approved by Qena School of Medicine Ethical
Committee (South Valley University, Qena, Egypt) and has
been conducted in Qena university hospital between January
2013 and April 2014. Informed consent was obtained from
every patient after explaining the procedures, the potential side
effects and possible outcomes.
2.1. Study design
Fig. 1 shows our study flowchart. We designed a prospective,
randomized, blind, steroid-controlled study. Eligible patients
were randomized into 2 groups using the closed envelope
method: Radiofrequency (RF) and steroid (S) group. Blinding
of our study was carried out that our patients were not aware
of their group assignment. Moreover, clinicians who per-
formed follow-up measurements and data collection were not
aware of the study group protocol. However, the pain inter-
ventionist who performed the interventions could not be
blinded to the procedure but was blind to the rest of the study
protocol.
In RF group, patients received RF ablation of L4–L5 med-
ial branch of primary dorsal rami, and S1 to S3 lateral branch
of the dorsal rami under fluoroscopy. In S group, 1 ml of40 mg/ml of depot methylprednisolone was given in the
sacroiliac joint under fluoroscopy. Patients in the steroid group
who did not show pain improvement were offered to cross over
to RF group and received radiofrequency (data not shown).
Those in the RF group who did not experience adequate symp-
tomatic relief, were labeled treatment failure and offered alter-
native treatment e.g., surgical fusion.
2.2. Outcome measures
We set our primary outcome to be at least 50% decrease in
pain intensity measured using VAS before and at 1, 3, and
6 months after intervention. Our secondary outcome was
P25% reduction in analgesic consumption. Analgesics con-
sumed were recorded before and after the intervention.
2.3. Enrollment
Patients suffer from low back pain for 6 months or more
requiring regular analgesia were eligible for the study accord-
ing to the following inclusion criteria: (1) Age more than
18 years; (2) American Society of Anesthetists (ASA) physical
status was I or II; and (3) Positive diagnostic SIJ block.
Our exclusion criteria included the following: (1) patients
with MRI evident of symptomatic disk herniation; spondy-
loarthropathy; facet arthropathy; fractures or tumors; (2)
patients with ASA III or more; (3) neurological deficits; (4)
coagulopathy; and (5) psychological illness that might compro-
mise an optimal response.
2.4. Diagnostic SIJ block
SIJ block was carried out by inserting spinal needles (20-
gauge) at the lower third of the SIJ in 15 degree contralateral
oblique C-arm view. Correct placement was confirmed by a
sacroiliac joint arthrogram. Then, a 3 ml solution containing
2 ml of Lidocaine 2% and 1 ml bupivacaine 0.5% was admin-
istered. After the block, patients were advised to move around
and fill up visual analogue scale (VAS) once hourly for 6 h
postblock. Positive diagnostic outcome was defined as 75%
pain relief for at least 3 h post block [25]. Otherwise the diag-
nostic SIJ block was considered negative and patient was
excluded from the study.
2.5. Radiofrequency ablation
Radiofrequency of L4 and L5 primary dorsal rami lesions was
undertaken using 22 gauge cannula (Neurotherm, Washing-
ton, MA, USA), with 10 mm active tips inserted parallel to
the nerve course till bone was hit at the junction between the
transverse process and superior articular processes for L4.
However, for L5 we inserted the needle between the ala and
the articular process of the sacrum [14,16]. To confirm that
the needles are in the right proximity of the target nerve, sen-
sory electro stimulation at 50 Hz, and 0.5 V or less was applied
with concordant sensation along the course of target nerve. To
ensure that the needles are far enough from the motor fibers,
absence of leg contraction in response to motor electro stimu-
lation at 2 Hz up to 2 V was verified before applying RF lesion.
Right before applying RF lesion, RF probe was taken out and
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Figure 1 Study flowchart.
Randomized, controlled blind study 2210.5 ml Lidocaine 2% was administered through each cannula
to decrease thermal pain and reduce the incidence of neuritis.
Then, RF probe was reinserted, and a lesion of 90 s and
80 C was applied using Neurotherm RF generator (Model
1100, USA).
For S1 down to S3 lateral-branch RF, 22-gauge 5 mm
active tips (Neurotherm, Washington MA, USA) were inserted
perpendicular to the bone between 3 and 5 mm to the lateral
border of the foramina. For S1 and S2 we performed 3 thermal
lesions and at S3, only two lesions were performed. In the
right-sided S1 and S2, the three lesions varied between 1:00,
and 5 o’clock positions on the face of a clock; on the left,
the sites were between 7, and 11:00. At S3, the two lesions were
performed at 1 and 4 on the right side, and 7 and 10 on the left.
We applied Sensory stimulation at each level merely for the
first needle insertion, eliciting concordant sensation at
60.5 volts.
Before applying RF lesion, 0.5 ml of lidocaine 2% per each
sacral level was administered. In order to confirm that anes-
thetic spread to other foramina did not affect sensory testing,RF probes were inserted and stimulated at adjacent levels
before denervation started. Once accurate needles position
was confirmed, RF probes were sequentially inserted into the
cannula and 90 s 80 C lesions were performed using Neu-
rotherm RF generator (Model 1100, USA).
2.6. Sample size
A pre-determined sample size was chosen by using a power
analysis based on our main (primary) outcome measure. In a
previous study sustained pain relief after steroid block was
0.35 [16]. Thus a sample size of 15 in each group was decided
to achieve a statistical power of 80% at a two sided significance
level of 0.05.
2.7. Statistics
Analysis of variance was used for intergroup comparisons.
Unpaired t-test was carried out for comparisons between
groups. Percentage and number of patients were used to report
Table 1 Patient characteristics.
S (n= 15) RF (n= 15)
Sex
Male (n= 12) 7 (46.6%) 5 (33.3%)
Female (18) 8 (53.3%) 10 (66, 6%)
Age (SD, range) 51.8 (13.1; 31–74) 51.9 (13.6; 27–75)
Weight in Kilograms (SD, Range) 74 (12.3; 67–82) 72 (13.4; 66–80)
Height in centimeters (SD, range) 168 (1.3; 163–175) 169 (1.6; 164–173)
Baseline VAS (SD, range) median (interquartile range) 6.4 (1.8; 3.5–10) 6 (5.5–7) 6.2 (1.8; 3–8) 6 (5–8)
Failed back surgery syndrome (n= 9)a 4 (26.6%) 5 (33. 3%)
Continuous data quoted as the mean (standard deviation, range), and median and (interquartile range, 25–75%), categorical data as number
and percentage.
a includes 5 patients with spinal fusion and 4 post-laminectomy.
Table 2 Percentage of patients with primary outcome (at least
50% decrease in pain intensity measured using VAS) at follow-
up visits.
Follow-up visits S group (n= 15) RF group (n= 15) (%)
At one month 20% 73a
At 3 months none 60a
At 6 months none 53a
* P< 0.05 as compared to steroid group.
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Figure 2 VAS scores: Baseline and follow-up at 1, 3, 6 months.
– P< 0.001 as compared to steroid group.
Table 3 VAS scores: Baseline and follow-up at 1, 3, 6 months.
Time S group
(n= 15)
RF group
(n= 15)
Baseline
Mean (SD, Range) 6.4 (1.8, 3.2–9.5) 6.2 (1.7, 3.5–8.6)
Median (interquartile
range)
6 (5–6.5) 6 (5–7.5)
One month
Mean (SD, Range) 6.2 (2.3, 3–10) 1.9 (1.7, 0–9)a,b
Median (interquartile
range)
7 (5–8) 3 (1–4)
Three months a,b
Mean (SD, Range) 6.4 (1.8, 3.2–9.5) 2.3 (2.4, 0–6)
Median (interquartile
range)
6 (5–6.5) 1.3 (1–4)
Six months a,b
Mean (SD, Range) None 2.6 (2.1, 0–6)
Median (interquartile
range)
2.3 (1.4–2.4)
a P< 0.05 as compared to steroid group.
b P< 0.05 as compared with same group baseline.
222 O.H. Salman et al.categorical data, and Fisher exact test was used for the
distribution of categorical variables. Statistical significance
was accepted for P less than 0.05.
3. Results
No complications happened and no patient dropped out of the
study.
3.1. Demographics
Patient characteristics including age, weight, height, male/
female ratio and baseline VAS scores, and the number of
patients with failed back syndrome were not significantly dif-
ferent (P> 0.05) between steroid and RF groups, Table 1.
3.2. Primary outcome
Table 2 shows percentage of patients with primary outcome. In
the RF group, 73%, 60% and 55% of patients, gainedP50%
pain relief at 1, 3 and 6 months respectively. In the S group, at
one month postintervention, only three patients (20%) gained
P50% pain relief, but failed to show any improvement at 3 or
6 months. Twelve patients in the S group crossed over to
receive radiofrequency ablation; at 1-month, one patient at
3 months (data not shown).
3.3. VAS scores follow-up
Fig. 2 shows that RF group had statistically significantly less
VAS mean scores than the steroid group ((1.9 ± 1.7; range
0–9) vs. (6.4 ± 1.8, 3.2–9.5), at one month and (2.3 ± 2.4;
range 0–6) vs. (6.2 ± 2.3, 3–10) at 3 months respectively,
Table 4 Percentage of patients with secondary outcome
(P25% reduction in analgesic consumption) at follow-up
visits.
Time S group (n= 15) RF group (n= 15) (%)
One month 16.2% 73.3a
Three months 0 60a
Six months 0 33.2a
a P< 0.05 as compared to steroid group. Confidence interval
(95% CI).
Randomized, controlled blind study 223P< 0.001). At 6 months, VAS mean in the RF group was 2.6
± 2.1 and the range was 0–6 and no patients remained in the S
group at 6 months.
Within-group analysis, in Table 3, shows that patients who
received radiofrequency intervention reported significantly
lower VAS mean scores at 1, 3 and 6 months post-
intervention compared to baseline scores (P< 0.001). In
contrast, the 1-month VAS scores of patients who had steroid
treatment were unchanged from baseline (P> 0.9). No more
within group analysis was done because of insufficient patient
number remaining in the steroid group at 3 and 6-month time
points.
3.4. Secondary outcome
Table 4 shows the percentage of patients who experienced 25%
reduction in their analgesic medications. In the steroid group it
was 16.2% at one month follow-up. In the radiofrequency
group, the percentage of patients who showed decrease in their
analgesic intake was 73.3% (n= 11), 60% (n= 9) and 33.3%
(n= 5) at 1, 3 and 6 months, respectively.4. Discussion
Our study reveals that radiofrequency ablation of L4–5 medial
branch of dorsal rami and S1_S3 lateral branches of dorsal
rami might ensure substantial pain relief and decrease anal-
gesic need in patients suffering from chronic painful sacroiliac.
At 1-, 3- and 6-months post-RF intervention, 73%, 60%
and 53% of patients, respectively, gained P50% pain relief.
This high incidence of pain relief was in accordance with
other studies that showed above average pain relief (P50%)
[26,27] and could be attributed to applying tight inclusion cri-
teria as well as the RF ablation technique as we created a con-
tinuous lesion in a wide area of tissue lateral to the S1–3
foramina used, rather than ablation of individual nerves. The
logic behind this approach is based on a cadaveric research
revealing a complex network of nerve fibers anastomosing with
multiple primary dorsal rami around each neural foramen [14].
Moreover, other studies using similar technique, showed
higher success rates than we obtained in ours; however, these
studies were open-label studies which tend to result in higher
outcome rate than in controlled studies [28]. This point needs
to be pursued in subsequent randomized trials, to detect the
role if there is any of RF lesion size in pain relief outcome.
Although individual nerve branch site was demonstrated to
differ according to the level, all nerves pass through a definite
tissue volume just between the lateral rim of the foramen andSIJ. By inserting RF probes around the foramen (multiple
sites), this definite tissue mass could be heated to neurolytic
temperature, and consequently occlude nociceptive signals to
the primary posterior ramus. Single RF application will poten-
tially miss some afferent fibers to the sacroiliac joint resulting
in poor or failed outcome [13,17].
Indeed, we designed our study to cross our patients over to
receive RF ablation at their 1-month follow-up, based on pilot
study data that showed the chances of someone gaining long-
term SIJ pain relief after steroid injection, if none was experi-
enced at 1-month postintervention, to be exceedingly low [29].
Moreover, our chief inclusion criterion of P75% decrease of
pain with diagnostic SI joint block has higher threshold than
that employed in other prior studies [14,16].
This potentially high inclusion threshold might have partic-
ipated in our high positive outcome rate. Thus, attention must
be sought when inferring these results to cases wherein less
strict inclusion criteria are employed. In a prevalence research
carried out in 43 patients with low back pain below L5–S1,
Schwarzer et al. showed that 30% obtained P75% pain relief
following sacroiliac joint block [22]. However, as the aim of
our study was to detect the therapeutic benefit, if any, of this
interventional technique, the use of rigorous inclusion criteria
was pursued to minimize the proportion of false-positive cases,
hence increasing the validity of the trial. Once the efficacy of
the intervention is established, subsequent studies can be car-
ried out with less strict inclusion criteria.
Although we designed strict inclusion criteria, still a consid-
erable number of patients did not show any significant
improvement in each of the studied groups. The high false-
positive proportion associated with single diagnostic sacroiliac
joint blocks [28], and the fact that the L4 through S3 primary
dorsal rami might not represent all the nerve supply to the
sacroiliac joint could be possible explanation. Applying double
confirmative diagnostic sacroiliac joint blocks using 2 dissimi-
lar local anesthetics may have improved the outcome and
decreased the failure up.
Prognostic blocking of lateral divisions might exclude those
with pain felt in the sacroiliac joint but not supplied by poste-
rior rami branches [30].
There were a couple of researches where SIJ block was
combined with lateral branch block to screen out patients eli-
gible for radiofrequency, and they showed that 89% patients
experienced more than 50% VAS reduction that lasted for
9 months [13–17].
A disappointing outcome of our study is the extended
radiofrequency lesion size we applied, and did not in fact lead
to substantial longer pain free duration. The duration of pain
relief is apparently influenced by nerve regeneration which
takes place between 6 months and one year [31,32]. Future
studies are needed to address whether innovations in the RF
technique (e.g. using bipolar rather than unipolar mode), or
in the inclusion requirements e.g. pain referral tendencies
and/or repeated RF ablations can influence duration of pain
relief or success rate for that matter.
One critique that might stand against this research is our
RF lesions that targeted five levels to obtain successful out-
come carry the risk of extensive tissue damage. However,
sacroiliac joint nerve supply is a matter of great controversy.
On the one hand, some researchers have detected nerve feeders
to the superior part of the SIJ from as far as L4 [1,33]. On the
other hand, other experts have failed to verify these findings
224 O.H. Salman et al.[34]. Nerve branches originating from the L4 and L5 dorsal
rami may not only supply the sacroiliac joint but they
innervate para-spinal muscles and ligaments, the L4–5 and
L5–S1 facet joint as well [31]. Whether a less extensive
RF lesion would result in better or worse outcome is a valid
point that should be investigated in future well controlled
studies.
It is worth mentioning that although diagnostic SIJ block
was mandatory for inclusion in this study, it has low specificity
[28,29]. Nevertheless, uncontrolled blocks of the sacroiliac
joint have high false-positive rate [24,30].
There are many limitations in our study. First, in spite
of the fact that our power analysis aimed at detection of
statistically significant differences between the studied
groups, was attested by positive outcome, the limited sam-
ple size in this research had the potential to produce several
variables that might influence the outcome including func-
tional ability/disability, the type of back surgery, and
patients with legal issues [15,31]. Recruiting patients in large
multi-center pilot study is warranted to verify our out-
comes, and it should be properly powered to be able to
detect these variables. Moreover, the small sample size stud-
ied in our research raises a concern regarding how safe this
extensive RF lesion was. Fifteen patients in each group are
not enough to pin out small albeit potentially risky neuro-
logical damage, that could be further cofounded by exten-
sive RF lesion used.
A second limitation is that we did not analyze the cross over
data. Radiofrequency after steroid block was not the focus of
our study.
In conclusion radiofrequency ablation at L4 and L5 pri-
mary dorsal rami and S1–3 lateral sacral branch may provide
effective and longer pain relief compared to the classic intra-
articular steroid injection, in properly screened patients with
painful sacroiliac joint pain. Larger studies are called for to
confirm our results, and lay out the optimal patient selection
and treatment parameters for this poorly comprehended
disorder.
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